Jefford M - Search Results

1

IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.

Luft T, Jefford M, Luetjens P, Hochrein H, Masterman KA, Maliszewski C, Shortman K, Cebon J, Maraskovsky E. Luft T, et al. Among authors: jefford m. J Immunol. 2002 Jan 15;168(2):713-22. doi: 10.4049/jimmunol.168.2.713. J Immunol. 2002. PMID: 11777965 Clinical Trial.

2

The use of dendritic cells in cancer therapy.

Jefford M, Maraskovsky E, Cebon J, Davis ID. Jefford M, et al. Lancet Oncol. 2001 Jun;2(6):343-53. doi: 10.1016/s1470-2045(00)00389-2. Lancet Oncol. 2001. PMID: 11905751 Review.

3

Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.

Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA, Maliszewski C, Shortman K, Cebon J, Maraskovsky E. Luft T, et al. Among authors: jefford m. Blood. 2002 Aug 15;100(4):1362-72. doi: 10.1182/blood-2001-12-0360. Blood. 2002. PMID: 12149219 Free article.

4

Rational approaches to human cancer immunotherapy.

Davis ID, Jefford M, Parente P, Cebon J. Davis ID, et al. Among authors: jefford m. J Leukoc Biol. 2003 Jan;73(1):3-29. doi: 10.1189/jlb.0502261. J Leukoc Biol. 2003. PMID: 12525559 Review.

5

Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli.

Jefford M, Schnurr M, Toy T, Masterman KA, Shin A, Beecroft T, Tai TY, Shortman K, Shackleton M, Davis ID, Parente P, Luft T, Chen W, Cebon J, Maraskovsky E. Jefford M, et al. Blood. 2003 Sep 1;102(5):1753-63. doi: 10.1182/blood-2002-12-3854. Epub 2003 May 8. Blood. 2003. PMID: 12738673 Free article.

6

The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.

Shackleton M, Davis ID, Hopkins W, Jackson H, Dimopoulos N, Tai T, Chen Q, Parente P, Jefford M, Masterman KA, Caron D, Chen W, Maraskovsky E, Cebon J. Shackleton M, et al. Among authors: jefford m. Cancer Immun. 2004 Sep 23;4:9. Cancer Immun. 2004. PMID: 15384929 Clinical Trial.

7

Informing and involving cancer patients in their own care.

Jefford M, Tattersall MH. Jefford M, et al. Lancet Oncol. 2002 Oct;3(10):629-37. doi: 10.1016/s1470-2045(02)00877-x. Lancet Oncol. 2002. PMID: 12372725 Review.

8

A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer.

Jefford M, Michael M, Rosenthal MA, Davis ID, Green M, McClure B, Smith J, Waite B, Zalcberg J. Jefford M, et al. Invest New Drugs. 2004 Apr;22(2):185-92. doi: 10.1023/B:DRUG.0000011796.20332.a9. Invest New Drugs. 2004. PMID: 14739668 Clinical Trial.

9

Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel.

Jefford M, Kiffer JD, Somers G, Daniel FJ, Davis ID. Jefford M, et al. ANZ J Surg. 2004 Aug;74(8):704-5. doi: 10.1111/j.1445-1433.2004.03130.x. ANZ J Surg. 2004. PMID: 15315581

10

Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors.

Goldstein D, Bell ML, Butow P, Sze M, Vaccaro L, Dong S, Liauw W, Hui R, Tattersall M, Ng W, Asghari R, Steer C, Vardy J, Parente P, Harris M, Karanth NV, King M, Girgis A, Eisenbruch M, Jefford M. Goldstein D, et al. Among authors: jefford m. Ann Oncol. 2014 Aug;25(8):1643-9. doi: 10.1093/annonc/mdu182. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827124 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters